NOTE: Trial E4512 is part of the Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials, four integrated precision medicine trials from the National Cancer Institute that are collectively known as ALCHEMIST.
Physician and Research Staff Educational Materials:
These materials are intended for promotional use among health care professionals and are NOT intended for use as patient educational materials.
Patient Educational Materials:
Participating sites should note that the Central Institutional Review Board (CIRB) has approved this material, which can be downloaded from the Clinical Trials Support Unit website (www.ctsu.org). The material is located under the E4512 Protocol; click on the CIRB Documents tab, and then Amendment Reviews. For sites utilizing local IRBs, please submit this in accordance with your local IRB policies prior to use.
Information and Assistance from the National Cancer Institute:
Additional Information on Cancer.gov: Displayed below is an interactive view of the study record as it appears in the government registry. If you are experiencing technical difficulties with this view, visit clinicaltrials.gov and search for record NCT02201992.